A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Patients With Non-Hodgkin's Lymphoma (NHL)

Update Il y a 4 ans
Reference: NCT00587015

Woman and Man

Extract

A dose-escalation study to estimate the maximum tolerated dose(MTD) of CAT-8015 that can be safely administered to a patient.


Inclusion criteria

  • LYMPHOMA

Links